Drug Profile
Botulinum toxin A - Mentor Corporation
Alternative Names: Botulinum toxin A - Mentor Worldwide; PurToxLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Mentor Corporation
- Developer Mentor Worldwide
- Class Analgesics; Anti-inflammatories; Antiarrhythmics; Antidepressants; Antimigraines; Antipruritics; Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Eye disorder therapies; Foot disorder therapies; Muscle relaxants; Recombinant proteins; Skin disorder therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Skin disorders; Torticollis
Most Recent Events
- 01 Jan 2014 No development reported - Phase-I/II for Torticollis in USA (IM)
- 01 Jun 2007 Phase-III clinical trials in Skin disorders (glabellar rhytides) in USA (IM)
- 01 May 2006 Phase-I/II clinical trials in Torticollis in USA (IM)